PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Review Article

Volume 8 Issue 3

Neurodegenerative Diseases Treatment Patent: White Paper

Christina Rahm*

September 02, 2026

View PDF

Abstract

Neurodegenerative diseases (Alzheimer development, Parkinson, and Huntington’s) are one of the emerging health challenges in the world which is characterized by the gradual destruction of brain cells and resultant cognitive and motor disability. The pathophysiology of these diseases is complicated and multifactorial and comprises a set of genetic, environmental, and biological determinants. Nevertheless, shared pathological pathways that support these disorders include oxidative stress, neuroinflammation, mitochondrial dysfunction and deposition of toxic proteins. Given the significance of these debilitating conditions, in the recent past, there have been scientific patents on new therapeutic formulations, which promise new avenues of fighting or relieving symptoms of the disease. This white paper discusses the potential contribution of a particular scientific patent, that consists of proprietary formulations to these mechanisms, to the treatment of neurodegenerative disease progress. The article identifies the causes of these diseases as oxidative stress, inflammation, mitochondrial pathology, and environmental toxins and how these patented formulations have the potential to provide therapeutic advantages.

References

  1. Altahrawi AY, James AW and Shah ZA. “The Role of Oxidative Stress and Inflammation in the Pathogenesis and Treatment of Vascular Dementia”. Cells 14.8 (2025): 609-609.
  2. Bailo P., et al. “The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies”. Advances in Laboratory Medicine 3.4 (2022): 342-350.
  3. Caproni S, Fonzo AD and Colosimo C. “Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain-Sport Crosstalk”. Parkinson's Disease 2025.1 (2025).
  4. Castelli S, Carinci E and Baldelli S. “Oxidative Stress in Neurodegenerative Disorders: A Key Driver in Impairing Skeletal Muscle Health”. International Journal of Molecular Sciences 26.12 (2025): 5782.
  5. Chen B., et al. “Mitochondrial quality control in neurodegenerative diseases: from molecular mechanisms to natural product therapies”. Frontiers in Physiology 16 (2025): 1695681-1695681.
  6. Chen G., et al. “Polyphenols and Alzheimer’s Disease: A Review on Molecular and Therapeutic Insights With In Silico Support”. Food Science & Nutrition 13.9 (2025).
  7. Folta J, Rzepka Z and Wrześniok D. “The Role of Inflammation in Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis”. International Journal of Molecular Sciences 26.11 (2025): 5177.
  8. Huang S-H., et al. “Association of zinc deficiency and risk of new-onset dementia: a retrospective cohort study”. Frontiers in Nutrition 12 (2025): 1666887-1666887.
  9. Islam MR., et al. “Neuroprotective Potential of Curcumin in Neurodegenerative Diseases: Clinical Insights Into Cellular and Molecular Signaling Pathways”. Journal of Biochemical and Molecular Toxicology 39.8 (2025).
  10. Jiao H., et al. “Curcumin and neuroplasticity: epigenetic mechanisms underlying cognitive enhancement in aging and neurodegenerative disorders”. Frontiers in Aging Neuroscience 17 (2025).
  11. Khan MS., et al. “Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases”. Frontiers in Physiology 16 (2025).
  12. Kulcsárová K, Piel A and Schaeffer E. “Environmental toxins in neurodegeneration - a narrative review”. Neurological Research and Practice 7.1 (2025).
  13. Lee J, Park S and Jang W. “Serum zinc deficiency could be associated with dementia conversion in Parkinson’s disease”. Frontiers in Aging Neuroscience 15 (2023).
  14. Mason S. “Say hello to my little friend… micro nutraceuticals in neuroenergetics, neuronal health, and neurodegenerative diseases”. Frontiers in Neuroscience 19 (2025).
  15. Ribeiro PR., et al. “Nutritional Approaches in Neurodegenerative Disorders: A Mini Scoping Review with Emphasis on SPG11-Related Conditions”. Nutrients 17.21 (2025): 3344.
  16. Tang S., et al. “Ferroptosis in neurodegenerative diseases: potential mechanisms of exercise intervention”. Frontiers in Cell and Developmental Biology 13 (2025): 1622544.
  17. Wang X., et al. “Unraveling the Vicious Cycle: Oxidative Stress and Neurotoxicity in Neurodegenerative Diseases”. FASEB BioAdvances 7.8 (2025).
  18. Yang HM. “Mitochondrial Dysfunction in Neurodegenerative Diseases”. Cells 14.4 (2025): 276.
  19. Zhang T., et al. “Ferroptosis in neurodegenerative diseases: mechanisms and therapeutic potential of stem cell derivatives”. Frontiers in Cell and Developmental Biology 13 (2025).